← All stocks

Stoke Therapeutics, Inc.

STOK Scheduled selling only

CIK 0001623526 #2049 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$170.06K

$170.06K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$170.06K

$0.00 against sales at will

By person

9 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ticho Barry

CHIEF MEDICAL OFFICER

—

$170.06K (2) scheduled

−$170.06K

20,110

0.0312%

$624.55K

+709.3%

Skorpios Trust entity

10% owner

—

3,906,181

6.05%

$121.31M

−56.1%

Krainer Adrian R.

Director

—

283,302

0.4390%

$8.80M

−30.0%

Kaye Edward M. MD

Director

—

124,557

0.1930%

$3.87M

+365.6%

TZIANABOS ARTHUR

Director

—

31,339

0.0486%

$973.29K

−1.3%

Allan Jonathan

GENERAL COUNSEL & CORP SEC

—

21,225

0.0329%

$659.18K

+167.4%

Hoitt Jason

Chief Patient Officer

—

10,276

0.0159%

$319.14K

+157.7%

Leggett Thomas

Chief Financial Officer

—

10,172

0.0158%

$315.91K

—

LEVIN ARTHUR A

Director

—

4,237

0.0066%

$131.59K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 20 Jun 2019